Physics World highlighted their recent Nature Methods paper that reported “optogenetically activated intracellular antibody”, or “optobodies”.

Research News

The optpbodies operates as a one-in-all platform that could help develop new therapies for cancer or autoimmune diseases. Professor HEO explains, “Our optobody system is a great tool to study the role of endogenous proteins in living cells and animals, and also shows great clinical promise for therapeutic strategies in the future.”
To read a full text, click (https://physicsworld.com/a/blue-light-activates-antibodies-on-demand/).